Serum MMP-9、peripheral leucocytes、and blood lipid of geriatric patients with acute cerebral infarction
The European Medicines Agency (EMEA) advises sponsors of epileptic disorder treatments in Phase III trials to use certain primary endpoints and include an adequate number of geriatric patients.
Larger trials are needed to definitively establish whether oral iron-replacement therapy is efficacious for correcting postoperative anemia in geriatric patients with a hip fracture.